To validate the involvement of KDM2B in TGF-β-induced EMT process, we used two different cancer cell lines, A549 lung cancer and Panc1 pancreatic cancer cells, and treated them with TGF-β. This evidence concerns the gene KDM2B and familial pancreatic carcinoma.